Veeva Systems Inc. (VEEV)
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Veeva initiated with an Overweight at Stephens
Stephens analyst Jeff Garro initiated coverage of Veeva with an Overweight rating and $280 price target. The company's sales growth stabilizing in the mid-teens, a return to 40%-plus EBITDA margins, and positive early feedback on the Vault transition have the shares delivering a strong share price performance over the last six months, the analyst tells investors in a research note. The firm says that relative to its own historical valuation multiple, Veeva is trading well below its 10-year average. It believes the company's next leg of growth through the new markets plan has potential to push the multiple back toward its 10-year average.
Here's Why you Should Retain Veeva Systems Stock in Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
Deciphering Veeva (VEEV) International Revenue Trends
Explore how Veeva's (VEEV) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Veeva Systems Q3 Earnings & Revenues Beat, Operating Margin Up Y/Y
VEEV's fiscal third-quarter results reflect impressive performance by the Subscription services segment, along with the expansion of gross and operating margins.
Veeva Systems: Normalization Of Macro Environment Is Positive For VEEV
I am positive on Veeva Systems (VEEV) due to expected growth acceleration as demand normalizes and strong product adoption continues. VEEV's latest earnings report showed impressive revenue growth and margin expansion, with upward revisions in FY25 guidance. The macro environment is stabilizing, which should benefit VEEV, as evidenced by improved demand visibility and positive industry comments.
Veeva Systems Inc. (VEEV) Q3 2025 Earnings Call Transcript
Veeva Systems Inc. (NYSE:VEEV ) Q3 2025 Earnings Conference Call December 5, 2024 5:00 PM ET Company Participants Gunnar Hansen - Director, Investor Relations Peter Gassner - Chief Executive Officer Paul Shawah - Executive Vice President, Strategy Brian Van Wagener - Chief Financial Officer Conference Call Participants Saket Kalia - Barclays Ken Wong - Oppenheimer Joe Vruwink - Baird Brian Peterson - Raymond James Ryan MacDonald - Needham and Company Anne Samuel - J.P. Morgan Dave Windley - Jefferies Gabriela Borges - Goldman Sachs Brent Bracelin - Piper Sandler Stan Berenshteyn - Wells Fargo Tyler Radke - Citi Craig Hettenbach - Morgan Stanley DJ Hynes - Canaccord Jailendra Singh - Truist Securities Andrew DeGasperi - BNP Paribas David Larsen - BTIG Charles Rhyee - TD Cowen Brad Sills - Bank of America Steven Valiquette - Mizuho Securities Operator Thank you for standing by.
Veeva (VEEV) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Veeva (VEEV) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Veeva Systems (VEEV) Q3 Earnings and Revenues Surpass Estimates
Veeva Systems (VEEV) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.34 per share a year ago.
Veeva initiated with an Outperform at Mizuho
Mizuho initiated coverage of Veeva with an Outperform rating and $275 price target. The firm says Veeva remains the market share leader in life science commercial and development cloud solutions. It expects the company's mid-teens sales to continue through fiscal 2028, noting the company is only 14% penetrated in its $20B total addressable market. Veeva's total revenue growth has rebounded this year, as the secular softening of end customer spending has slowly improved, the analyst tells investors in a research note.
